Dr. Keta Vagha
undergraduation from Jawaharlal Nehru Medical College,
Title: Neurodevelopment assessment of children with congenital heart disease by applying Denver developmental screening test ( DDST-II).
Biography
Biography: Dr. Keta Vagha
Abstract
The prevalence of congenital heart disease (CHD) is estimated to be 9 per 1000 live births. Children with CHD are under risk of delayed growth and development. Neurodevelopmental delay in children with CHD is reported to be more common with cyanotic CHD, and in those requiring surgical intervention. There are many developmental screening tools. DDST-II is a formal developmental screening tool that assesses children from birth to 6 years of age. There is scarce information available on the neurodevelopmental status of Indian children with CHD thus this study was conducted. AIM- To assess the neurodevelopmental status in a child with CHD by applying the Denver Developmental Screening Test (DDST-II). Objectives: To determine the prevalence of developmental delay in children with CHD and comparison of neurodevelopmental status in children with acyanotic and cyanotic CHD. Methods- Cross-sectional study; cases of CHD were included after confirmation by 2-D ECHO and children with recognizable genetic syndromes were excluded. DDST-II was performed on these children and developmental delay was determined. Results- DDST-II showed developmental delay in 65 out of 82 children(79.26%) with more predilection in children with cyanotic congenital heart disease (85.71%). Conclusion- The children with congenital heart disease are more susceptible for developmental delay with predilection for cyanotic congenital heart diseases. Early recognition and palliative treatment can provide these children a better life.